Viemed Healthcare Inc
TSX:VMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (7.4), the stock would be worth CA$10.45 (0% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.4 | CA$10.45 |
0%
|
| 3-Year Average | 7.4 | CA$10.45 |
0%
|
| 5-Year Average | 7.4 | CA$10.55 |
+1%
|
| Industry Average | 18.7 | CA$26.5 |
+154%
|
| Country Average | 16.7 | CA$23.67 |
+126%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Viemed Healthcare Inc
TSX:VMD
|
402.3m CAD | 7.4 | 31.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.1B USD | 13.8 | 54.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 10.6 | 13.3 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.4B USD | 0 | 12.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.9B EUR | 12.4 | 18.3 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 11 | 23.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.4B USD | 14.4 | 22.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD | 16.4 | 25.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 6.6 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.7B USD | -66.1 | -28.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 10.4 | 14 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
Viemed Healthcare Inc
Glance View
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana. The company went IPO on 2017-12-22. Viemed is focused on providing in-home treatment with clinical practitioners and providing therapy, and counseling to patients in their homes using technology. Viemed’s products and services include Home Medical Equipment and In-home sleep testing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. The company provides home medical equipment through a range of service programs, including respiratory disease management, Neuromuscular care, Oxygen therapy and Sleep apnea. In-home sleep testing provides in home sleep apnea testing services, which is an alternative to the traditional sleep lab testing environment.
